688319 logo

Chengdu Olymvax Biopharmaceuticals Inc. Stock Price

SHSE:688319 Community·CN¥9.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688319 Share Price Performance

CN¥22.55
11.93 (112.34%)
CN¥22.55
11.93 (112.34%)
Price CN¥22.55

688319 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with questionable track record.

1 Risk
2 Rewards

Chengdu Olymvax Biopharmaceuticals Inc. Key Details

CN¥709.1m

Revenue

CN¥44.3m

Cost of Revenue

CN¥664.8m

Gross Profit

CN¥600.6m

Other Expenses

CN¥64.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.16
93.75%
9.05%
40.1%
View Full Analysis

About 688319

Founded
2009
Employees
463
CEO
Shaowen Fan
WebsiteView website
www.olymvax.com

Chengdu Olymvax Biopharmaceuticals Inc. engages in the research and development, production, and sales of vaccines for human use in China. The company offers absorbed tetanus vaccine, group a and group c products; and haemophilus influenzae type b. It also provides Hib conjugate vaccine and AC conjugate vaccine; and group A and C meningococcal polysaccharide conjugate vaccine. The company was founded in 2009 and is based in Chengdu, China.

Recent 688319 News & Updates

Recent updates

No updates